Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program offers hope for chronic back pain sufferers

NCT ID NCT07406711

Symptom relief Sponsor: Osijek University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a multidisciplinary biopsychosocial program—combining physical, psychological, and social support—works better than standard multimodal treatment for people with chronic low back pain. 128 adults aged 18-65 took part over four weeks. Researchers measured pain, disability, quality of life, and emotional well-being to see which approach provided more relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Nov 2021

Finished

May 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years * Chronic low back pain significantly affecting disability and/or emotional distress * Active use of Croatian language * Signed informed consent Exclusion Criteria: * Age \<18 or \>65 * Acute pain * Previous participation in multidisciplinary program * Pregnancy or cancer-related pain * Psychotic disorders, moderate-severe cognitive impairment, urgent psychiatric conditions * PTSD symptoms, extreme fatigue, low motivation, low literacy * Allergic reactions to metal or silicone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic low back pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic low back pain Multidisciplinary biopsychosocial program Quality of life

Contacts and locations

Locations

  • University Hospital Osijek

    Osijek, 31000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.